Diaceutics PLC PDMR Shareholding/Share Incentive Plan (4196N)

TIDMDXRX

RNS Number : 4196N

Diaceutics PLC

31 May 2022

31 May 2022

Diaceutics PLC

("Diaceutics" or "the Company")

PDMR Shareholding/Share Incentive Plan

Diaceutics PLC , ( AIM: DXRX), the diagnostic commercialisation company has been notified that on 27 May 2022, Yorkshire Building Society and Zedra Trust Company (Guernsey) Limited, the trustees of the Global Diaceutics plc 2020 Employee Benefit Trust , have purchased ordinary shares ("Shares") on behalf of Stefan McDonald and Susanne Munksted (PDMRs), in respect of their purchase of Shares pursuant to the Company's UK and Global Share Incentive Plan ("the SIP Schemes") for employees . These purchases will be made each month until further notice.

In accordance with the SIP Schemes, the Company has matched these purchases with a matched share award over an equivalent number of Shares purchased by the employee, in the proportion of 1:1.

Enquiries:

 
 
  Diaceutics PLC 
Nick Roberts, Chief Financial Officer                        Via Alma PR 
 
Stifel Nicolaus Europe Limited (Nomad & Broker)      Tel: [phone] 
                                                                    7600 
Ben Maddison 
Stewart Wallace 
Nick Adams 
 
Alma PR                                               Tel: [phone] 
                                                                    0205 
Caroline Forde                                   [e-mail] 
Kieran Breheny 
Matthew Young 
 

About Diaceutics

At Diaceutics we believe that every patient should have access to the right treatment at the right time. We provide the world's leading pharmaceutical companies with an end-to-end solution for the launch of precision medicine diagnostics enabled by DXRX - The Diagnostic Network(R).

DXRX is the world's first diagnostic commercialisation platform for precision medicine, integrating multiple pipelines of real-world diagnostic testing data from a global network of laboratories.

 
 Notification of a Transaction pursuant to Article 19(1) of Regulation 
  (EU) No. 596/2014 
 1     Details of the person discharging managerial responsibilities/person 
        closely associated 
----  ----------------------------------------------------------------------------------- 
 a.    Name                         Stefan McDonald 
                                   ------------------------------------------------------ 
 2     Reason for notification 
      ---------------------------  ------------------------------------------------------ 
 a.    Position/Status              Chief Growth Officer and PDMR 
      ---------------------------  ------------------------------------------------------ 
 b.    Initial notification/        Initial 
        Amendment 
                                   ------------------------------------------------------ 
 3     Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
 a.    Name                         Diaceutics PLC 
      --------------------------- 
 b.    LEI                          213800VEWQBB39ZB8J81 
      ---------------------------  ------------------------------------------------------ 
 4     Details of the transaction(s): section to be repeated for 
        (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transactions have 
        been conducted 
----  ----------------------------------------------------------------------------------- 
 a.    Description of               Ordinary shares of GBP 0.002 each 
        the financial 
        instrument, type             ISIN: GB00BJQTGV64 
        of instrument 
 
        Identification 
        Code 
      ---------------------------  ------------------------------------------------------ 
 b.    Nature of the                Ongoing non-discretionary purchase of Shares 
        transaction                  matched by the grant of conditional share 
                                     award over Shares under the Diaceutics plc 
                                     UK Share Incentive Plan ("SIP") 
      ---------------------------  ------------------------------------------------------ 
 c.    Price(s) and volume(s)              Share purchase: 
      ---------------------------         -----------------------------   ---  ---------- 
                                           Price(s)      Volume(s) 
      ---------------------------         ------------ 
                                           111.90 p      134 
                                          ------------  ---------------- 
                                            Matched share award: 
                                          ------------------------------ 
                                           Price(s)      Volume(s) 
                                          ------------ 
                                           111.90 p      134 
                                          ------------  ---------------- 
 
 e.    Date of the transaction      Share purchase and Matched Share award: 
                                     27 May 2022 
      ---------------------------  ------------------------------------------------------ 
 f.    Place of the transaction     Share Purchase and Matched Share Award: 
                                     AIM Market of the London Stock Exchange 
      ---------------------------  ------------------------------------------------------ 
 
 
 
 Notification of a Transaction pursuant to Article 19(1) of Regulation 
  (EU) No. 596/2014 
 1     Details of the person discharging managerial responsibilities/person 
        closely associated 
----  ----------------------------------------------------------------------------------- 
 a.    Name                         Susanne Munksted 
                                   ------------------------------------------------------ 
 2     Reason for notification 
      ---------------------------  ------------------------------------------------------ 
 a.    Position/Status              Chief Precision Medicine Officer and PDMR 
      ---------------------------  ------------------------------------------------------ 
 b.    Initial notification/        Initial 
        Amendment 
                                   ------------------------------------------------------ 
 3     Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
 a.    Name                         Diaceutics PLC 
      --------------------------- 
 b.    LEI                          213800VEWQBB39ZB8J81 
      ---------------------------  ------------------------------------------------------ 
 4     Details of the transaction(s): section to be repeated for 
        (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transactions have 
        been conducted 
----  ----------------------------------------------------------------------------------- 
 a.    Description of               Ordinary shares of GBP 0.002 each 
        the financial 
        instrument, type             ISIN: GB00BJQTGV64 
        of instrument 
 
        Identification 
        Code 
      ---------------------------  ------------------------------------------------------ 
 b.    Nature of the                Ongoing non-discretionary purchase of Shares 
        transaction                  matched by the grant of conditional share 
                                     award over Shares under the Global Share 
                                     Incentive Plan ("SIP") 
      ---------------------------  ------------------------------------------------------ 
 c.    Price(s) and volume(s)              Share purchase: 
      ---------------------------         -----------------------------   ---  ---------- 
                                           Price(s)      Volume(s) 
      ---------------------------         ------------ 
                                           112.00 p      131 
                                          ------------  ---------------- 
                                           Conditional share award: 
                                          ------------------------------ 
                                           Price(s)      Volume(s) 
                                          ------------ 
                                           Nil           131 
                                          ------------  ---------------- 
 
 e.    Date of the transaction      Share purchase and Conditional share award: 
                                     27 May 2022 
      ---------------------------  ------------------------------------------------------ 
 f.    Place of the transaction     Share Purchase: AIM Market of the London 
                                     Stock Exchange 
                                     Conditional share award: Off-Market 
      ---------------------------  ------------------------------------------------------ 
 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHBKDBKDBKDCPN

(END) Dow Jones Newswires

May 31, 2022 07:12 ET (11:12 GMT)